Keros Therapeutics, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $115.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $438.8K | 0.4% |
| Stock Repurchases | $107.1M | 92.5% |
| Working Capital | $8.2M | 7.1% |
| Net Cash Flow | $0 | 0.0% |
Net Cash Flow Breakdown
Total Cash from Operations: $115.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $438.8K | 0.4% |
| Stock Repurchases | $107.1M | 92.5% |
| Working Capital | $8.2M | 7.1% |
| Net Cash Flow | $0 | 0.0% |